Company intelligence / Profile preview

NeoSyAD Technologies

France

Ownership: Private
Development stage: Other

Overview

NEOSYAD’s "AdiMate" device and "Adipure" kit offer automated, high-quality adipose tissue purification for lipofilling, with outcomes validated in breast reconstruction. EU MDR approval demonstrates safety and efficacy. Results highlight rapid operating time (<10 minutes), tissue viability, and enhanced precision.

Therapeutic areas: Women's HealthOtherDermatology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Partnerships

MicroAire Surgical Instruments (strategic and acquisition partner)

Beyond the preview

Go deeper on NeoSyAD Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoSyAD Technologies.

Explore the full profile